Research Trial Assessing the Immunogenicity and Safety of Three Meningococal B Vaccine Strategies Among Patients With Asplenia.
Condition:   Splenectomy Interventions:   Biological: Trumenba®;   Biological: Bexsero® Sponsors:   Assistance Publique - Hôpitaux de Paris;   EUCLID Clinical Trial Platform;   Recherche Clinique Paris Descartes Necker Cochin Sainte Anne;   CIC 1417 Cochin Pasteur;   Innovative clinical research in vaccinologie (I-REIVAC);   Institut Pasteur Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials